Profiling of primary peripheral blood- and monocyte-derived dendritic cells using monoclonal antibodies from the HLDA10 Workshop in Wollongong, Australia

Clinical and Translational Immunology

Volumn 4, Issue 11, 2015, Pages

  Autenrieth, Stella E ^a   Grimm, Sabrina ^a   Rittig, Susanne Malaika ^a   Grünebach, Frank ^a   Gouttefangeas, Cécile ^b   Bühring, Hans Jörg ^a  

^a UNIVERSITY HOSPITAL TÜBINGEN   (Germany)

^b UNIVERSITY OF TÜBINGEN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIGEN; CD135 ANTIGEN; CD141 ANTIGEN; CD1C ANTIGEN; CD303 ANTIGEN; INTERLEUKIN 4; LYMPHOCYTE ANTIGEN; MONOCLONAL ANTIBODY; UNCLASSIFIED DRUG; VIMENTIN;

ARTICLE; AUSTRALIA; CONTROLLED STUDY; DENDRITIC CELL; FLOW CYTOMETRY; HUMAN; HUMAN CELL; IMMUNOPHENOTYPING; IN VITRO STUDY; MONOCYTE; PERIPHERAL BLOOD DENDRITIC CELL; PLASMACYTOID DENDRITIC CELL; PRIORITY JOURNAL;

EID: 85043614228     PISSN: None     EISSN: 20500068     Source Type: Journal    
DOI: 10.1038/cti.2015.29     Document Type: Article

References (30)

1. Steinman RM, Banchereau J. Taking dendritic cells into medicine. Nature 2007; 449: 419–426.
2. Banchereau J, Briere F, Caux C, Davoust J, Lebecque S, Liu Y-J et al. Immunobiology of dendritic cells. Annu Rev Immunol 2000; 18: 767–811.
3. Guermonprez P, Valladeau J, Zitvogel L, Théry C, Amigorena S. Antigen presentation and T cell stimulation by dendritic cells. Annu Rev Immunol 2002; 20: 621–667.
4. Trombetta ES, Mellman I. Cell biology of antigen presentation in vitro and in vivo. Annu Rev Immunol 2005; 23: 975–1028.
5. Villadangos JA, Schnorrer P. Intrinsic and cooperative antigen-presenting functions of dendritic-cell subsets in vivo. Nat Rev Immunol 2007; 7: 543–555.
6. Reis e Sousa C. Dendritic cells in a mature age. Nat Rev Immunol 2006; 6: 476–483.
7. Reizis B, Bunin A, Ghosh HS, Lewis KL, Sisirak V. Plasmacytoid dendritic cells: recent progress and open questions. Annu Rev Immunol 2011; 29: 163–183.
8. Robbins SH, Walzer T, Dembélé D, Thibault C, Defays A, Bessou G et al. Novel insights into the relationships between dendritic cell subsets in human and mouse revealed by genome-wide expression profiling. Genome Biol 2008; 9: R17.
9. Durand M, Segura E. The known unknowns of the human dendritic cell network. Front Immun 2015; 6: 1–7.
10. Sancho D, Mourão-Sá D, Joffre OP, Schulz O, Rogers NC, Pennington DJ et al. Tumor therapy in mice via antigen targeting to a novel, DC-restricted C-type lectin. J Clin Invest 2008; 118: 2098–2110.
11. Huysamen C, Willment JA, Dennehy KM, Brown GD. CLEC9A is a novel activation C-type lectin-like receptor expressed on BDCA3+ dendritic cells and a subset of monocytes. J Biol Chem 2008; 283: 16693–16701.
12. Caminschi I, Proietto AI, Ahmet F, Kitsoulis S, Shin Teh J, Lo JCY et al. The dendritic cell subtype-restricted C-type lectin Clec9A is a target for vaccine enhancement. Blood 2008; 112: 3264–3273.
13. + dendritic cells. J Exp Med 2010; 207: 1273–1281.
14. Crozat K, Guiton R, Contreras V, Feuillet V, Dutertre C-A, Ventre E et al. The XC chemokine receptor 1 is a conserved selective marker of mammalian cells homologous to mouse CD8alpha+ dendritic cells. J Exp Med 2010; 207: 1283–1292.
15. + dendritic cells. J Exp Med 2010; 207: 1261–1271.
16. + dendritic cells (DCs) represent a unique myeloid DC subset that cross-presents necrotic cell antigens. J Exp Med 2010; 207: 1247–1260.
17. Mittag D, Proietto AI, Loudovaris T, Mannering SI, Vremec D, Shortman K et al. Human dendritic cell subsets from spleen and blood are similar in phenotype and function but modified by donor health status. J Immunol 2011; 186: 6207–6217.
18. + T cells to produce type 2 cytokines. J Immunol 2014; 193: 4335–4343.
19. Jin JO, Zhang W, Du JY, Yu Q. BDCA1-positive dendritic cells (DCs) represent a unique human myeloid DC subset that induces innate and adaptive immune responses to Staphylococcus aureus infection. Infect Immun 2014; 82: 4466–4476.
20. Caux C, Dezutter-Dambuyant C, Schmitt D, Banchereau J. GM-CSF and TNF-alpha cooperate in the generation of dendritic Langerhans cells. Nature 1992; 360: 258–261.
21. Sallusto F, Lanzavecchia A. Efficient presentation of soluble antigen by cultured human dendritic cells is maintained by granulocyte/macrophage colony-stimulating factor plus interleukin 4 and downregulated by tumor necrosis factor alpha. J Exp Med 1994; 179: 1109–1118.
22. Palucka AK. Dendritic cells as the terminal stage of monocyte differentiation. J Immunol 1998; 160: 4587–4595.
23. Chen W, Antonenko S, Sederstrom JM, Liang X, Chan ASH, Kanzler H et al. Thrombopoietin cooperates with FLT3-ligand in the generation of plasmacytoid dendritic cell precursors from human hematopoietic progenitors. Blood 2004; 103: 2547–2553.
24. Geijtenbeek TB, Torensma R, van Vliet SJ, van Duijnhoven GC, Adema GJ, van Kooyk Y et al. Identification of DC-SIGN, a novel dendritic cell-specific ICAM-3 receptor that supports primary immune responses. Cell 2000; 100: 575–585.
25. Han D, Walsh MC, Cejas PJ, Dang NN, Kim YF, Kim J et al. Dendritic cell expression of the signaling molecule TRAF6 is critical for gut microbiota-dependent immune tolerance. Immunity 2013; 38: 1211–1222.
26. Chiba S, Baghdadi M, Akiba H, Yoshiyama H, Kinoshita I, Dosaka-Akita H et al. Tumor-infiltrating DCs suppress nucleic acid–mediated innate immune responses through interactions between the receptor TIM-3 and the alarmin HMGB1. Nat Immunol 2012; 13: 832–842.
27. Sancho D, Joffre OP, Keller AM, Rogers NC, Martínez D, Hernanz-Falcón P et al. Identification of a dendritic cell receptor that couples sensing of necrosis to immunity. Nature 2009; 458: 899–903.
28. + T cell responses. J Immunol 2010; 185: 3504–3513.
29. Willment JA, Marshall ASJ, Reid DM, Williams DL, Wong SYC, Gordon S et al. The human beta-glucan receptor is widely expressed and functionally equivalent to murine Dectin-1 on primary cells. Eur J Immunol 2005; 35: 1539–1547.
30. + T cells by targeting antigens to human dendritic cells through DCIR. Blood 2010; 116: 1685–1697.